Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2215INDUSTRY 1405NIH 392NETWORK 68OTHER_GOV 36FED 7UNKNOWN 4INDIV 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 78Breast 49Thoracic 29Head & Neck 16Lymphoid 14CNS 9Other hematologic neoplasm 7Gynecologic 6Genitourinary 4Dermatologic 4Sarcoma 3Other solid neoplasm 2Other neoplasm 2Tumor-Agnostic 1NET 1Myeloid 1Endocrine 1

Conditions

Melanoma 4Urinary Bladder Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Skin Diseases 1Ovarian Neoplasms 1Neoplasms 1Hutchinson's Melanotic Freckle 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

pembrolizumab 1Equipment and Supplies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × Dermatologic × Clear all
NCT02346955 2020-08-27

MK-6018-001

KitovPharma

Phase 1 Terminated
27 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00785369 2012-10-03

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Lucid

Phase NA Completed
441 enrolled
Dermatologic

Melanoma, Skin Diseases, Skin Neoplasms, Hutchinson's Melanotic Freckle

NCT00399113 2011-07-14

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

PainT

Phase 1 Completed
12 enrolled
Dermatologic

Melanoma

NCT00734188 2011-07-14

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

PainT

Phase 1 Completed
21 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡